Anthem Blue Cross 2001 Annual Report Download - page 42

Download and view the complete annual report

Please find page 42 of the 2001 Anthem Blue Cross annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 72

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72

We also maintain a diverse portfolio of large capitalization equity securities. An immediate 10% decrease in
each equity investment’s value, arising from market movement, would result in a fair value decrease of $18.9
million. Alternatively, an immediate 10% increase in each equity investment’s value, attributable to the same
factor, would result in a fair value increase of $18.9 million. No portion of our equity portfolio was invested
in non-US dollar denominated investments as of December 31, 2001. As of December 31, 2001, we held no
derivative financial or commodity-based instruments.
This management’s discussion and analysis contains certain forward-looking information. Words such as “expect(s)”,
“feel(s)”, “believe(s)”, “will”, “may”, “anticipate(s)”, “estimate(s)”, “should”, “intend(s)” and similar expressions are
intended to identify forward-looking statements. Such statements are subject to known and unknown risks and
uncertainties that could cause actual results to differ materially from those projected. These risks and uncertainties
may include: trends in healthcare costs and utilization rates; our ability to secure sufficient premium rate increases;
competitor pricing below market trends of increasing costs; increased government regulation of health benefits and
managed care; significant acquisitions or divestitures by major competitors; introduction and utilization of new
prescription drugs and technology; a downgrade in our financial strength ratings; litigation targeted at health
benefits companies; our ability to contract with providers consistent with past practice; and general economic
downturns. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only
as of the date hereof. We undertake no obligation to republish revised forward-looking statements to reflect events or
circumstances after the date hereof or to reflect the occurrence of unanticipated events.
40